Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care ("POC") diagnostic tests for infectious diseases. Chembio plans to use the signal enhancing technology for its Dual Path Platform (“DPP®”) rapid d...
Tags: immunoassay, point of care solutions, infectious diseases
Show per page
1 of 1 Page
Popular tags in SelectScience